Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug development in the era of personalized oncology: from population-based trials to enrichment and prescreening strategies.

Dienstmann R, Rodon J, Tabernero J. Drug development in the era of personalized oncology: from population-based trials to enrichment and prescreening strategies. Am Soc Clin Oncol Educ Book. 2012; 168-72.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.